feed,title,long_url,short_url
MarketWatch,Synairgen stock sinks 85% as COVID-19 treatment misses trial targets,https://www.marketwatch.com/bulletins/redirect/go?g=%7BD25B28B2-EF3A-4322-B4A3-5D41947E0A8C%7D&siteid=bulletrss,https://on.mktw.net/3s4LUSl
